NCT01577186View on ClinicalTrials.gov

Symptomatic Remission and Social Function in Participants Treated With Paliperidone Extended Release (ER)

PHASE4CompletedINTERVENTIONAL

Enrollment

480

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions

Schizophrenia

Interventions

DRUG

Paliperidone ER

Participants will receive paliperidone ER tablet in flexible dose range of 3 to 12 milligram per day (mg/day) orally once daily up to Week 12 as per Investigator's discretion.